Maple Rock Capital Partners’s Adient ADNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-512,630
Closed -$20.9M 31
2022
Q1
$20.9M Buy
512,630
+394,630
+334% +$16.9M 1.11% 20
2021
Q4
$5.65M Buy
+118,000
New +$5.29M 0.6% 25

Other funds holding ADNT

Maple Rock Capital Partners's ADNT Position: Q2 2022 in Review

Maple Rock Capital Partners sold out of Adient (ADNT) in Q2 2022, closing a stake of 512,630 shares — an estimated $20.9M sold.

Maple Rock Capital Partners first reported a position in ADNT in Q4 2021 and held it in 2 quarters. The position peaked at $20.9M in Q1 2022. 258 funds tracked by Wall St. Rank hold ADNT as of Q2 2022.

  • Maple Rock Capital Partners reported no remaining Adient position as of Q2 2022 after selling out during the quarter.
  • Maple Rock Capital Partners sold 512,630 Adient shares in Q2 2022, an estimated $20.9M.
  • Maple Rock Capital Partners first reported a position in Adient in Q4 2021 and held it in 2 quarters.
  • Maple Rock Capital Partners's Adient position peaked at $20.9M in Q1 2022.
  • 258 funds tracked by Wall St. Rank held Adient as of Q2 2022.

Based on Maple Rock Capital Partners's 13F filing for Q2 2022, filed 15 Aug 2022.